AI Analysis AI Analysis of INMB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add INMB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in Inmune stock price on Friday which ended trading at $1.26
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jun 05, 2026

The Inmune stock price fell by -6.67% on the last day (Friday, 5th Jun 2026) from $1.35 to $1.26. During the last trading day the stock fluctuated 10.48% from a day low at $1.24 to a day high of $1.37. The price has fallen in 6 of the last 10 days and is down by -12.5% for this period. Volume has increased on the last day by 15 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 327 thousand shares were bought and sold for approximately $412.48 thousand.

Given the current short-term trend, the stock is expected to rise 15.28% during the next 3 months and, with a 90% probability hold a price between $1.45 and $2.00 at the end of this 3-month period.

INMB Signals & Forecast

There are few to no technical positive signals at the moment. The Inmune stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.37 and $1.43. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 14, 2026, and so far it has fallen -25.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Inmune gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Inmune stock

Inmune finds support from accumulated volume at $1.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.130 between high and low, or 10.48%. For the last week, the stock has had daily average volatility of 8.12%.

Inmune is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: $1.19 (-5.54%) (This stock has medium daily movements and this gives medium risk. Low RSI14 is 23 which reduces the risk some. There is a sell signal from a pivot top found 15 days ago.)

Trading Expectations (INMB) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Inmune Bio Inc. to open at $1.29, and during the day (based on 14 day Average True Range), to move between $1.21 and $1.31, which gives a possible trading interval of +/-$0.101 (+/-8.33%) up or down from last closing price. If Inmune Bio Inc. takes out the full calculated possible swing range there will be an estimated 8.33% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.24 (1.59%) than the resistance at $1.31 (3.97%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Inmune Bio Inc. stock A Buy?

Inmune holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.563 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.29 ( 2.38%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

INMB Performance

Trading levels for INMB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.42 12.70%
R2 1.37 8.76%
R1 1.34 6.32%
Price 1.26
S1 1.24 -1.56%
S2 1.21 -4.00%
S3 1.16 -7.94%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.42 12.70%
R2 1.33 5.56%
R1 1.31 3.97%
Price 1.26
S1 1.24 -1.59%
S2 1.23 -2.38%
S3 1.17 -7.14%

FAQ

What is the symbol for Inmune Stock and on which exchange is it traded?
The symbol for Inmune is INMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Inmune Stock?
Inmune holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Inmune Stock?
Inmune Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inmune Stock.

What's the current price of Inmune Stock?
As of the end of day on the Jun 05, 2026, the price of an Inmune (INMB) share was $1.26.

What is the 52-week high and low for Inmune Stock?
The 52-week high for Inmune Stock is $11.64 and the 52-week low is $1.09.

What is the market capitalization of Inmune Stock?
As of the Jun 05, 2026, the market capitalization of Inmune is 33.497M.

When is the next earnings date for Inmune?
The upcoming earnings date for Inmune is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT INMUNE BIO INC.
Inmune
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic synd...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE